Cargando…

Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease: Promising, but Work in Progress

Intestinal ultrasound (IUS) is increasingly used and promulgated as a noninvasive monitoring tool for children with inflammatory bowel disease because other diagnostic modalities such as colonoscopy and magnetic resonance imaging cause significant stress in the pediatric population. The most importa...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Wassenaer, Elsa A, Benninga, Marc A, van Limbergen, Johan L, D’Haens, Geert R, Griffiths, Anne M, Koot, Bart G P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071066/ https://www.ncbi.nlm.nih.gov/pubmed/34013955 http://dx.doi.org/10.1093/ibd/izab125

Ejemplares similares

Assessing Disease Activity in Pediatric Crohn’s Disease Using Ultrasound: The Pediatric Crohn Disease Intestinal Ultrasound Score
por: van Wassenaer, Elsa A., et al.
Publicado: (2023)

Intestinal Ultrasound to Assess Ulcerative Colitis Disease Activity in Children: External Validation and Comparison of 2 Intestinal Ultrasound Activity Indices
por: van Wassenaer, Elsa A, et al.
Publicado: (2022)

Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease
por: De Voogd, Floris, et al.
Publicado: (2021)

Can 2 Different Fecal Calprotectin Assays be Used Interchangeably in IBD Treatment?
por: van Wassenaer, Elsa A., et al.
Publicado: (2022)

Bowel ultrasound measurements in healthy children — systematic review and meta-analysis
por: van Wassenaer, Elsa A., et al.
Publicado: (2019)

Diagnostic Accuracy of Transabdominal Ultrasound in Detecting Intestinal Inflammation in Paediatric IBD Patients—a Systematic Review
por: van Wassenaer, Elsa A, et al.
Publicado: (2019)

The child’s perception on monitoring inflammatory bowel disease activity
por: van Wassenaer, Elsa A., et al.
Publicado: (2021)

Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound Index
por: Bots, Steven, et al.
Publicado: (2021)

Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease
por: Hoekman, Daniël R., et al.
Publicado: (2016)

Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease
por: Hart, Lara, et al.
Publicado: (2021)

The current status of non-radiologist-performed abdominal ultrasonography in paediatrics – a scoping literature review protocol
por: van Wassenaer, Elsa A., et al.
Publicado: (2019)

Non-radiologist-performed abdominal point-of-care ultrasonography in paediatrics — a scoping review
por: van Wassenaer, Elsa A., et al.
Publicado: (2021)

Hemolytic anemia after switching from infliximab originator to biosimilar CT‐P13 in a patient with inflammatory bowel disease: A case report
por: Strik, Anne S., et al.
Publicado: (2019)

Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial
por: Hoekman, Daniël R, et al.
Publicado: (2020)

A Reliability Study: Strong Inter-Observer Agreement of an Expert Panel for Intestinal Ultrasound in Ulcerative Colitis
por: De Voogd, Floris, et al.
Publicado: (2021)

Nutritional Therapy Strategies in Pediatric Crohn’s Disease
por: Verburgt, Charlotte M., et al.
Publicado: (2021)

Impaired Quality of Working Life in Inflammatory Bowel Disease Patients
por: van Gennep, Sara, et al.
Publicado: (2020)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease
por: Garrido, Hannah M Garcia, et al.
Publicado: (2021)

Case report of cheilitis granulomatosa and joint complaints as presentation of Crohn’s disease
por: Hoekman, Daniël R., et al.
Publicado: (2016)

A prospective study comparing patient-reported outcomes in Crohn’s disease
por: Hoekman, Daniël R., et al.
Publicado: (2020)

Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study
por: Jagt, Jasmijn Z., et al.
Publicado: (2021)

The Role of the Lymphatic System in the Pathogenesis and Treatment of Inflammatory Bowel Disease
por: Nikolakis, Dimitrios, et al.
Publicado: (2022)

Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review
por: Colombel, Jean-Frédéric, et al.
Publicado: (2020)

Next-Generation Therapeutics for IBD
por: Löwenberg, Mark, et al.
Publicado: (2015)

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease
por: Spekhorst, Lieke M, et al.
Publicado: (2017)

Intestinal ultrasound detects an increased diameter and submucosal layer thickness in the appendix of patients with ulcerative colitis compared to healthy controls – a prospective cohort study
por: Reijntjes, Maud A., et al.
Publicado: (2022)

Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study
por: Yarlas, Aaron, et al.
Publicado: (2018)

Intestinal Ultrasound Early on in Treatment Follow-up Predicts Endoscopic Response to Anti-TNFα Treatment in Crohn’s Disease
por: de Voogd, F, et al.
Publicado: (2022)

Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study
por: Jagt, Jasmijn Z, et al.
Publicado: (2021)

Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study
por: Willian, Mary Kaye, et al.
Publicado: (2018)

Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease
por: Draijer, Laura G., et al.
Publicado: (2019)

High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study
por: van Gennep, Sara, et al.
Publicado: (2020)

Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study
por: Hanzel, Jurij, et al.
Publicado: (2021)

The Role of Succinate in the Regulation of Intestinal Inflammation
por: Connors, Jessica, et al.
Publicado: (2018)

Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation
por: Berends, Sophie E., et al.
Publicado: (2019)

Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting
por: Volkers, Adriaan, et al.
Publicado: (2023)

The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease
por: De Vries, L.C.S., et al.
Publicado: (2017)

Assessing the Clinical and Endoscopic Efficacy of Extended Treatment Duration with Different Doses of Mesalazine for Mild-to-Moderate Ulcerative Colitis beyond 8 Weeks of Induction
por: D’Haens, Geert, et al.
Publicado: (2023)

Faecal Metabolomics in Paediatric Inflammatory Bowel Disease: A Systematic Review
por: Jagt, Jasmijn Z, et al.
Publicado: (2022)

The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms
por: Frigerio, Sofía, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_55ovr70eadae7kb2pgn75p9mkb